4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-054901
Director sold 5,000 shares at an average $177.48 ($887,411)
From the SEC's structured data for this filing
Trades in this filing
STUELPNAGEL JOHN R · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-01 | Sale : show line 1 in the form | −300 | $175.36 | $52,607 | 381,316 | D |
| 2021-09-01 | Sale : show line 2 in the form | −1,000 | $176.36 | $176,356 | 380,316 | D |
| 2021-09-01 | Sale : show line 3 in the form | −2,300 | $177.62 | $408,535 | 378,016 | D |
| 2021-09-01 | Sale : show line 4 in the form | −1,104 | $178.34 | $196,884 | 376,912 | D |
| 2021-09-01 | Sale : show line 5 in the form | −296 | $179.15 | $53,030 | 376,616 | D |
| Open-market sales · 5,000 sh · avg $177.48 · $887,411 | ||||||
Loading xslF345X03/doc4.xml…